ARVN - Financial Reports List - Arvinas, Inc. - IntrinsicAlpha

Arvinas, Inc. ARVN

Healthcare - Biotechnology - NASDAQ - US

$ 8.75

1.74 %

$ 602 M

Market Cap

-3.16

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	237.35%	70.87%	64.79%
Annual Report	FY	10-K	2024-12-31	235.54%	45.85%	37.68%
Quarterly Report	Q3	8-K	2024-09-30	195.95%	23.12%	18.40%
Quarterly Report	Q2	8-K	2024-06-30	40.37%	47.15%	34.99%
Quarterly Report	Q1	8-K	2024-03-31	-22.15%	14.11%	5.02%
Quarterly Report	Q4	8-K	2023-12-31	-113.42%	-93.74%	-119.23%
Annual Report	FY	10-K	2023-12-31	-40.26%	-35.09%	-52.55%
Quarterly Report	Q3	8-K	2023-09-30	14.19%	3.32%	-9.97%
Quarterly Report	Q2	8-K	2023-06-30	74.12%	4.86%	-9.22%
Quarterly Report	Q1	8-K	2023-03-31	34.30%	-27.44%	-46.17%

1